We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Epizyme Achieves $4 Million Pre-Clinical Milestone Payment in Eisai Strategic Partnership

News   Jan 13, 2012

 
Epizyme Achieves $4 Million Pre-Clinical Milestone Payment in Eisai Strategic Partnership
 
 
 

RELATED ARTICLES

Myelin-thinning Gene Linked to Psychiatric Disorders

News

Scientists have identified a specific gene they believe could be a key player in the changes in brain structure seen in several psychiatric conditions, such as schizophrenia and autism.

READ MORE

First-degree Relatives of Blood Cancer Patients at Greater Risk

News

Those with a parent, sibling or child affected by blood cancer are more likely to be diagnosed with the disease, according to a new study.

READ MORE

Studying Cells’ “Self-eating” Could Help Create New Dementia Drugs

News

A team from the University of Plymouth has shed light on the mechanisms behind cell "self-eating" and how it progresses. They hope that this information could be used to direct efforts towards new treatment for dementia.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE